v3.26.1
CONDENSED STATEMENTS OF CASH FLOWS - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:        
Net income     $ 881,113 $ 2,899,551
Adjustments to reconcile net income to net cash used in operating activities:        
Interest income earned on investments held in Trust Account $ (2,075,700) $ (1,733,912) (4,119,710) (1,733,912)
Change in fair value of warrant liability   (1,435,682)   (1,435,682)
Changes in current assets and liabilities        
Prepaid Expenses     8,996 (231,465)
Deferred offering costs       248,425
Accounts Payable     120,055  
Accrued Expenses     2,512,737 50,211
Due to related party     (2,425) (121,358)
Net cash used in operating activities     (599,234) (324,230)
Cash flows from investing activities:        
Investment of cash in Trust Account       (226,125,000)
Net cash used in investing activities       (226,125,000)
Cash flows from financing activities:        
Proceeds from the sale of Units       226,125,000
Proceeds from issuance of promissory note - related party       397,800
Payment of promissory note - related party       (550,000)
Proceeds from sale of private placement warrants       7,568,750
Payment of underwriting fee       (4,500,000)
Payment of offering costs       (1,624,662)
Net cash provided by financing activities       227,416,888
Net change in cash     (599,234) 967,658
Cash, beginning of the period     856,131 2,232
Cash, end of the period $ 256,897 $ 969,890 $ 256,897 969,890
Supplemental disclosure of cash flow information:        
Deferred underwriters' discount payable charged to additional paid-in capital       9,000,000
Forfeiture of Class B ordinary shares       166,667
Deferred offering costs included in accrued expenses       $ 1,402